Segall Bryant & Hamill LLC Buys Shares of 152,580 Vital Farms, Inc. (NASDAQ:VITL)

Segall Bryant & Hamill LLC purchased a new stake in shares of Vital Farms, Inc. (NASDAQ:VITL - Free Report) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund purchased 152,580 shares of the company's stock, valued at approximately $4,649,000. Segall Bryant & Hamill LLC owned about 0.34% of Vital Farms at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in VITL. CIBC Private Wealth Group LLC increased its position in Vital Farms by 152.1% in the 4th quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock worth $35,000 after buying an additional 540 shares during the period. Frazier Financial Advisors LLC acquired a new stake in Vital Farms in the 4th quarter valued at $59,000. CWM LLC boosted its stake in Vital Farms by 43.2% in the 1st quarter. CWM LLC now owns 2,154 shares of the company's stock valued at $66,000 after buying an additional 650 shares in the last quarter. Union Bancaire Privee UBP SA acquired a new stake in Vital Farms in the 1st quarter valued at $112,000. Finally, Hanson & Doremus Investment Management acquired a new position in Vital Farms in the first quarter worth $130,000. 98.59% of the stock is currently owned by institutional investors and hedge funds.

Vital Farms Trading Down 0.8%

VITL traded down $0.32 during midday trading on Monday, reaching $37.09. 283,070 shares of the company's stock traded hands, compared to its average volume of 1,019,388. The firm has a fifty day moving average of $35.21 and a two-hundred day moving average of $35.24. The stock has a market capitalization of $1.65 billion, a price-to-earnings ratio of 33.04 and a beta of 0.94. The company has a debt-to-equity ratio of 0.03, a current ratio of 3.35 and a quick ratio of 2.91. Vital Farms, Inc. has a 52 week low of $27.91 and a 52 week high of $45.72.

Vital Farms (NASDAQ:VITL - Get Free Report) last announced its earnings results on Thursday, May 8th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.26 by $0.11. Vital Farms had a return on equity of 19.53% and a net margin of 8.26%. The firm had revenue of $162.19 million during the quarter, compared to analyst estimates of $164.43 million. During the same quarter in the prior year, the company earned $0.43 EPS. The business's revenue was up 9.7% compared to the same quarter last year. On average, equities analysts anticipate that Vital Farms, Inc. will post 1.11 earnings per share for the current fiscal year.

Insider Activity at Vital Farms

In other Vital Farms news, insider Matthew Ohayer sold 30,000 shares of the stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $39.17, for a total transaction of $1,175,100.00. Following the sale, the insider directly owned 6,858,890 shares in the company, valued at approximately $268,662,721.30. This trade represents a 0.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Thilo Wrede sold 1,200 shares of the firm's stock in a transaction on Friday, July 11th. The stock was sold at an average price of $38.97, for a total value of $46,764.00. Following the completion of the transaction, the chief financial officer owned 56,187 shares in the company, valued at approximately $2,189,607.39. This trade represents a 2.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 62,400 shares of company stock worth $2,211,930 in the last 90 days. 21.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on VITL. Morgan Stanley dropped their target price on Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. BMO Capital Markets upgraded Vital Farms to a "strong-buy" rating in a research note on Tuesday, May 6th. Mizuho began coverage on Vital Farms in a report on Tuesday, July 8th. They issued an "outperform" rating and a $45.00 target price on the stock. Finally, Telsey Advisory Group reissued an "outperform" rating and set a $52.00 price objective on shares of Vital Farms in a report on Monday, May 5th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $44.67.

Vital Farms Company Profile

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.